Skip to main content

Table 2 Case series/reports investigating intermittent fasting in patients with type 2 diabetes

From: Intermittent fasting: is there a role in the treatment of diabetes? A review of the literature and guide for primary care physicians

Intermittent Fasting Protocol

Description

Effects of Intermittent Fasting vs. Baseline

Alternate Day Fasting

One day of fasting/One day of ad libitum feeding

Furmli et al. [26] (7 months)

Average Baseline Values:

HbA1C: 11%, 96.7 mmol/mol

Body weight: 83.8 kg

Results:

- Decreased HbA1C by 4%

- Decreased body weight by 10 kg

 

Furmli et al. [26] (11 months)

Average Baseline Values:

HbA1C: 7.2%, 55.2 mmol/mol

Body weight: 61 kg

Results:

- Decreased HbA1C by 0.8%

- Decreased body weight by 9 kg

Furmli et al. [26] (11 months)

Average Baseline Values:

HbA1C: 6.8%, 50.8 mmol/mol

Body weight: 97.1 kg

Results:

- Decreased HbA1C by 1.2%

- Decreased body weight by 10.6 kg

Lichtash et al. [27] (14 months)

Average Baseline Values

HbA1C: 9.3%

Body Weight: 55.3 kg

Results:

- Decreased HbA1C by 3.5%

- Decreased body weight by 1.8 kg